| Literature DB >> 25453092 |
Anju Sreelatha1, Terry L Bennett2, Emily M Carpinone2, Kevin M O'Brien2, Kamyron D Jordan2, Dara L Burdette1, Kim Orth1, Vincent J Starai3.
Abstract
Vesicle fusion governs many important biological processes, and imbalances in the regulation of membrane fusion can lead to a variety of diseases such as diabetes and neurological disorders. Here we show that the Vibrio parahaemolyticus effector protein VopQ is a potent inhibitor of membrane fusion based on an in vitro yeast vacuole fusion model. Previously, we demonstrated that VopQ binds to the V(o) domain of the conserved V-type H(+)-ATPase (V-ATPase) found on acidic compartments such as the yeast vacuole. VopQ forms a nonspecific, voltage-gated membrane channel of 18 Å resulting in neutralization of these compartments. We now present data showing that VopQ inhibits yeast vacuole fusion. Furthermore, we identified a unique mutation in VopQ that delineates its two functions, deacidification and inhibition of membrane fusion. The use of VopQ as a membrane fusion inhibitor in this manner now provides convincing evidence that vacuole fusion occurs independently of luminal acidification in vitro.Entities:
Keywords: SNARE; Vibrio parahaemolyticus; vesicle fusion; vp1680; yeast vacuole
Mesh:
Substances:
Year: 2014 PMID: 25453092 PMCID: PMC4291640 DOI: 10.1073/pnas.1413764111
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205